Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of the New Drug Application (NDA) for Oclaiz™ (CAM2029), ...
A Python GUI application for calculation of stock and working dilutions. This tool helps researchers quickly calculate the exact amounts needed to prepare stock solutions from powder and dilute stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback